AP2007004084A0 - Taurine synthesis production and utility as a medicine - Google Patents
Taurine synthesis production and utility as a medicineInfo
- Publication number
- AP2007004084A0 AP2007004084A0 AP2007004084A AP2007004084A AP2007004084A0 AP 2007004084 A0 AP2007004084 A0 AP 2007004084A0 AP 2007004084 A AP2007004084 A AP 2007004084A AP 2007004084 A AP2007004084 A AP 2007004084A AP 2007004084 A0 AP2007004084 A0 AP 2007004084A0
- Authority
- AP
- ARIPO
- Prior art keywords
- medicine
- utility
- synthesis production
- taurine synthesis
- taurine
- Prior art date
Links
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 title 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 229960003080 taurine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EG2005010013 | 2005-01-05 | ||
| PCT/EG2005/000044 WO2006072259A2 (en) | 2005-01-05 | 2005-12-31 | Taurine synthesis, production and utility as a medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AP2007004084A0 true AP2007004084A0 (en) | 2007-08-31 |
Family
ID=36647837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AP2007004084A AP2007004084A0 (en) | 2005-01-05 | 2005-12-31 | Taurine synthesis production and utility as a medicine |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1844006A2 (en) |
| JP (1) | JP2008526789A (en) |
| KR (1) | KR20070091198A (en) |
| CN (1) | CN101146767A (en) |
| AP (1) | AP2007004084A0 (en) |
| AU (1) | AU2005324199A1 (en) |
| BR (1) | BRPI0519606A2 (en) |
| CA (1) | CA2593563A1 (en) |
| EA (1) | EA200701434A1 (en) |
| IL (1) | IL184221A0 (en) |
| MA (1) | MA29238B1 (en) |
| MX (1) | MX2007008196A (en) |
| NO (1) | NO20074937A (en) |
| TN (1) | TNSN07226A1 (en) |
| WO (1) | WO2006072259A2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5583022B2 (en) | 2007-11-30 | 2014-09-03 | ザ レジェンツ オブ ザ ユニヴァースティ オブ カリフォルニア | Method for treating non-alcoholic steatohepatitis (NASH) using cysteamine product |
| CN103382170B (en) * | 2012-10-25 | 2015-04-08 | 潜江永安药业股份有限公司 | Preparation method for taurine |
| CN106728405A (en) * | 2016-11-15 | 2017-05-31 | 陈思文 | A kind of taurine and water soluble tea polyphenol compound and preparation method and application |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58140017A (en) * | 1981-12-22 | 1983-08-19 | Junichi Azuma | Remedy for cardiac insufficiency |
| JPH08208464A (en) * | 1994-12-02 | 1996-08-13 | Taisho Pharmaceut Co Ltd | Treatment and prevention drug for hyperlipidemia |
| US6184227B1 (en) * | 1995-07-21 | 2001-02-06 | Savvipharm Inc. | Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |
| SE9601395D0 (en) * | 1996-04-12 | 1996-04-12 | Dieter Haeussinger | New therapeutic treatment 1 |
| GB9722361D0 (en) * | 1997-10-24 | 1997-12-17 | Pharma Nord Uk Ltd | Pharmaceutical formulation for treating liver disorders |
| NZ527924A (en) * | 1999-01-29 | 2005-01-28 | Mars Uk Ltd | Antioxidant compositions and methods for companion animals |
| WO2001026642A2 (en) * | 1999-10-08 | 2001-04-19 | Joyce Corinne Bechthold | Methods and compositions for treating neurobehavioral disorders |
| CN1340502A (en) * | 2000-06-30 | 2002-03-20 | 张永春 | Process for preparing taurine zinc |
| CN1268733C (en) * | 2004-07-20 | 2006-08-09 | 刘辉 | Taurine functional beer and its producing process |
-
2005
- 2005-12-31 MX MX2007008196A patent/MX2007008196A/en not_active Application Discontinuation
- 2005-12-31 WO PCT/EG2005/000044 patent/WO2006072259A2/en not_active Ceased
- 2005-12-31 CA CA002593563A patent/CA2593563A1/en not_active Abandoned
- 2005-12-31 EA EA200701434A patent/EA200701434A1/en unknown
- 2005-12-31 AP AP2007004084A patent/AP2007004084A0/en unknown
- 2005-12-31 BR BRPI0519606-0A patent/BRPI0519606A2/en not_active IP Right Cessation
- 2005-12-31 EP EP05818935A patent/EP1844006A2/en not_active Withdrawn
- 2005-12-31 JP JP2007549796A patent/JP2008526789A/en active Pending
- 2005-12-31 CN CNA2005800460663A patent/CN101146767A/en active Pending
- 2005-12-31 KR KR1020077016443A patent/KR20070091198A/en not_active Withdrawn
- 2005-12-31 AU AU2005324199A patent/AU2005324199A1/en not_active Abandoned
-
2007
- 2007-06-14 TN TNP2007000226A patent/TNSN07226A1/en unknown
- 2007-06-26 IL IL184221A patent/IL184221A0/en unknown
- 2007-07-26 MA MA30110A patent/MA29238B1/en unknown
- 2007-09-28 NO NO20074937A patent/NO20074937A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TNSN07226A1 (en) | 2008-11-21 |
| JP2008526789A (en) | 2008-07-24 |
| NO20074937A (en) | 2007-09-28 |
| MA29238B1 (en) | 2008-02-01 |
| WO2006072259A3 (en) | 2007-10-04 |
| WO2006072259A2 (en) | 2006-07-13 |
| MX2007008196A (en) | 2008-02-22 |
| EP1844006A2 (en) | 2007-10-17 |
| CA2593563A1 (en) | 2006-07-13 |
| KR20070091198A (en) | 2007-09-07 |
| BRPI0519606A2 (en) | 2009-02-25 |
| CN101146767A (en) | 2008-03-19 |
| IL184221A0 (en) | 2008-12-29 |
| AU2005324199A1 (en) | 2006-07-13 |
| EA200701434A1 (en) | 2008-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200711081B (en) | Synthesis gas production and use | |
| ZA200800562B (en) | Efficient production of hydrogen | |
| IL181588A0 (en) | PRODUCTION OF-TNFR-Ig | |
| ZA200710190B (en) | Process to prepare a blended brightstock | |
| IL190476A0 (en) | Biomass hydrolysate and uses and production thereof | |
| IL200705A0 (en) | New micro-organisms for the production of 1,2-propanediol obtained by a combination of evolution and rational design | |
| ZA200708947B (en) | Production of Synthesis Gas | |
| ZA200810504B (en) | Process to prepare a synthesis gas | |
| GB0402469D0 (en) | Production of a fermentation product | |
| GB0505064D0 (en) | Production of bio-diesel | |
| GB0402470D0 (en) | Production of a fermentation product | |
| GB0808916D0 (en) | Production of conjugates | |
| GB0507947D0 (en) | Improvements to a table | |
| AP2007004084A0 (en) | Taurine synthesis production and utility as a medicine | |
| GB0614245D0 (en) | Synthesis process | |
| GB2424248B (en) | Improvements to a retaining ring | |
| GB0423081D0 (en) | Hydrogen production | |
| HK1105119A (en) | Taurine synthesis, production and utility as a medicine | |
| HK1103070A (en) | Taurine synthesis, production and utility as a medicine | |
| GB0614246D0 (en) | Synthesis process | |
| ZA200706091B (en) | General solvent synthesis, production and utility | |
| GB0509068D0 (en) | Ethanol production | |
| GB0525796D0 (en) | Hydrogen Production | |
| GB0504948D0 (en) | Energy production | |
| PL381684A1 (en) | The manner of production of a microsensor |